selected publications
- Can we talk about sex? Feasibility of universal sexual health screening for BRCA1/2 patients. The journal of sexual medicine. 2025 Academic Article GET IT
- Bridging Gaps in Cervical Cancer Care: A Web-Based Intervention to Improve Knowledge and Follow-up. Journal of lower genital tract disease. 2024 Academic Article GET IT
-
Transgelin 2 guards T cell lipid metabolism and antitumour function.
Nature.
2024
Academic Article
GET IT
Times cited: 32 -
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer.
Cancer discovery.
2024
Academic Article
GET IT
Times cited: 16 - Updates in the Use of Targeted Therapies for Gynecologic Cancers. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2024 Review GET IT
- Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic. Gynecologic oncology. 2024 Academic Article GET IT
-
Building knowledge using a novel web-based intervention to promote HPV vaccination in a diverse, low-income population.
Gynecologic oncology.
2024
Academic Article
GET IT
Times cited: 6 - Transgelin 2 guards T cell lipid metabolic programming and anti-tumor function. 2023 GET IT
-
Patient and provider perspectives on telemedicine use in an outpatient gynecologic clinic serving a diverse, low-income population.
Journal of telemedicine and telecare.
2023
Academic Article
GET IT
Times cited: 2 -
Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis.
JCO clinical cancer informatics.
2023
Review
GET IT
Times cited: 22 -
Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis.
Gynecologic oncology.
2023
Review
GET IT
Times cited: 6 -
Attitudes and beliefs regarding complementary and alternative medicine in a diverse gynecologic oncology patient population.
Gynecologic oncology reports.
2023
Academic Article
GET IT
Times cited: 1 -
Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.
Gynecologic oncology.
2023
Academic Article
GET IT
Times cited: 6 -
Web-based tool for cancer family history collection: A prospective randomized controlled trial.
Gynecologic oncology.
2023
Academic Article
GET IT
Times cited: 13 -
Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis.
PEC innovation.
2023
Academic Article
GET IT
Times cited: 25 -
What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.
Cancer.
2022
Academic Article
GET IT
Times cited: 8 -
Understanding Perceived Barriers to Colposcopy Follow-Up Among Underserved Women at an Urban Teaching Hospital: A Qualitative Study.
Journal of lower genital tract disease.
2022
Academic Article
GET IT
Times cited: 9 -
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2022
Review
GET IT
Times cited: 89 -
Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting.
Gynecologic oncology reports.
2022
Academic Article
GET IT
Times cited: 8 -
Leveraging Health Information Technology to Collect Family Cancer History: A Systematic Review and Meta-Analysis.
JCO clinical cancer informatics.
2021
Review
GET IT
Times cited: 10 -
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.
Gynecologic oncology.
2021
Review
GET IT
Times cited: 62 -
Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic.
Gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 32 -
Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins.
Oncotarget.
2019
Academic Article
GET IT
Times cited: 7 -
Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6.
Frontiers in pharmacology.
2019
Academic Article
GET IT
Times cited: 8 -
Less Is More: Minimally Invasive and Quality Surgical Management of Gynecologic Cancer.
Obstetrics and gynecology clinics of North America.
2019
Review
GET IT
Times cited: 1 -
HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells.
Clinical and experimental immunology.
2018
Academic Article
GET IT
Times cited: 12 - Therapeutic Molecular Biomarkers in Gynecological Cancers. Rhode Island medical journal (2013). 2015 Academic Article GET IT
-
Debulking surgery and intraperitoneal chemotherapy are associated with decreased morbidity in women receiving neoadjuvant chemotherapy for ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2014
Academic Article
GET IT
Times cited: 3 -
Immediate postplacental IUD insertion at cesarean delivery: a prospective cohort study.
Contraception.
2012
Academic Article
GET IT
Times cited: 52